Blauvelt, NY, United States of America

John Robert Coleman

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of John Robert Coleman

Introduction

John Robert Coleman is a notable inventor based in Blauvelt, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments for cancer. With a total of six patents to his name, his work has the potential to impact the medical community profoundly.

Latest Patents

One of Coleman's latest patents is focused on a recombinant virus with a codon-pair deoptimized region, which is designed for the treatment of various forms of malignant tumors. This invention utilizes engineered recombinant viruses that replace certain regions of the wild type virus with synthetic recoded sequences. These modifications aim to reduce the codon pair score relative to human codon pair bias, enhancing the effectiveness of the treatment for cancers affecting organs such as the breast, skin, colon, and brain. Remarkable remissions have been observed in experimental animals, particularly for malignant glioblastoma multiforme and breast cancer.

Another significant patent involves modified Flavivirus, including a modified Zika virus. This invention reduces the expression of viral proteins compared to the parent virus by recoding specific regions. The modified Flavivirus serves as a vaccine composition, providing a protective immune response against infections.

Career Highlights

Coleman has worked with esteemed institutions such as the State University of New York and Codagenix, Inc. His research and innovations have positioned him as a key figure in the biotechnology sector, contributing to advancements in viral therapies and vaccine development.

Collaborations

Throughout his career, Coleman has collaborated with notable scientists, including Steffen Mueller and Eckard Wimmer. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

John Robert Coleman is a pioneering inventor whose work in biotechnology has the potential to revolutionize cancer treatment and vaccine development. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…